No.
But in terms of some of the other issues you raise, I think I'm the first health minister to have raised the issue of generic prices, which tend to be higher in our country than elsewhere, and it does impede our ability to put new drugs on the formulary when we're paying 15%, 20%, 25% higher in this country than some of our trade partners.
So that is an issue. A lot of the levers, though, are held by the provinces, I must say. When you talk about kickbacks at pharmacies and whatnot, as you may know, Ontario has taken a run at this and other provinces are following suit. So I certainly am commending provinces that are taking this seriously because I think in the end, as these blockbusters come off patent over the next 10 to 15 years, that will provide us with the savings we need to reinvest in catastrophic drugs and expensive drugs for rare diseases.
